Biosensors is a medical device company known for its innovations in interventional cardiology, particularly in the field of coronary stents. The BioMatrix platform includes a range of drug-eluting stents (DES) designed to be used in the treatment of coronary artery disease.
Key features of the BioMatrix stent platform, which may extend to the NeoFlex model if it's a part of the series, may include:
Drug-Eluting Stent: The stents in the BioMatrix platform are drug-eluting, meaning they are coated with a medication (such as an anti-restenotic drug) designed to inhibit the regrowth of tissue inside the treated blood vessel.
Biodegradable Polymer: Some versions of the BioMatrix stent use a biodegradable polymer to deliver the drug to the target site. The polymer gradually dissolves over time, leaving only the metallic stent behind.
Flexible Design: The stents are designed to be flexible, allowing for easier navigation and deployment in the coronary arteries.
Thin-Strut Technology: Thin struts can contribute to improved deliverability and conformability of the stent to the vessel wall.
Various Sizes: The BioMatrix stent platform typically offers stents in various sizes to accommodate different patient anatomies and lesion characteristics.
